EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

What the Hel: recent advances in understanding rifampicin resistance in bacteria

Petra Sudzinová, Hana Šanderová, Tomáš Koval', Tereza Skálová, Nabajyoti Borah, Jarmila Hnilicová, Tomáš Kouba, Jan Dohnálek, Libor Krásný iD

FEMS Microbiology Reviews · 01.11.2023 · 47 (6)

DOI: 10.1093/femsre/fuac051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbiology Reviews, online erschienen am 22.12.2022. Verfasst von Petra Sudzinová und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbial Genetics and Gene Expression, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech …. Hauptthemen laut MEDLINE: Rifampin, Bacteria. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IBT CAS, Czech Science Foundation, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rifampicin is a clinically important antibiotic that binds to, and blocks the DNA/RNA channel of bacterial RNA polymerase (RNAP). Stalled, nonfunctional RNAPs can be removed from DNA by HelD proteins; this is important for maintenance of genome integrity. Recently, it was reported that HelD proteins from high G+C Actinobacteria, called HelR, are able to dissociate rifampicin-stalled RNAPs from DNA and provide rifampicin resistance. This is achieved by the ability of HelR proteins to dissociate rifampicin from RNAP. The HelR-mediated mechanism of rifampicin resistance is discussed here, and the roles of HelD/HelR in the transcriptional cycle are outlined. Moreover, the possibility that the structurally similar HelD proteins from low G+C Firmicutes may be also involved in rifampicin resistance is explored. Finally, the discovery of the involvement of HelR in rifampicin resistance provides a blueprint for analogous studies to reveal novel mechanisms of bacterial antibiotic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinBacteriaDNA-Directed RNA PolymerasesAnti-Bacterial AgentsDrug Resistance, BacterialDNA

Stichwörter der Autor:innen

HelD/HelRRNA polymeraseantibioticsbacteriaresistancerifampicin

Substanzen

RifampinDNA-Directed RNA PolymerasesAnti-Bacterial AgentsDNA

Autor:innen und Institutionen

  • Laboratory of Microbial Genetics and Gene Expression, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.
  • Laboratory of Structure and Function of Biomolecules, Institute of Biotechnology of the Czech Academy of Sciences, Centre BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
  • Cryogenic Electron Microscopy Research-Service Group, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, 16000 Prague, Czech Republic.

ORCID-Profile: Libor Krásný

Förderung

  • IBT CAS
  • Czech Science Foundation
  • European Regional Development Fund
  • National Institute of Virology and Bacteriology

Zitieren

APA

Sudzinová, P., Šanderová, H., Koval', T., Skálová, T., Borah, N., Hnilicová, J., Kouba, T., Dohnálek, J., & Krásný, L. (2023). What the Hel: recent advances in understanding rifampicin resistance in bacteria. FEMS Microbiology Reviews, 47(6). https://doi.org/10.1093/femsre/fuac051

Vancouver

Sudzinová P, Šanderová H, Koval' T, Skálová T, Borah N, Hnilicová J, et al. What the Hel: recent advances in understanding rifampicin resistance in bacteria. FEMS Microbiology Reviews. 2023;47(6). doi:10.1093/femsre/fuac051

BibTeX
@article{Sudzinov2023,
  author = {Sudzinová, Petra and Šanderová, Hana and Koval', Tomáš and Skálová, Tereza and Borah, Nabajyoti and Hnilicová, Jarmila and Kouba, Tomáš and Dohnálek, Jan and Krásný, Libor},
  title = {What the Hel: recent advances in understanding rifampicin resistance in bacteria},
  journal = {FEMS Microbiology Reviews},
  year = {2023},
  volume = {47},
  number = {6},
  doi = {10.1093/femsre/fuac051}
}
Kostenlos starten →